AGY

ALLERGY THERAPEUTICS PLC ORD 0.1P

TitleTime
Second Price Monitoring ExtnMon 18/05/20 | 14:05
Price Monitoring ExtensionMon 18/05/20 | 14:00
Second Price Monitoring ExtnThu 23/04/20 | 16:41
Price Monitoring ExtensionThu 23/04/20 | 16:36
Grant and Vesting of AwardsWed 01/04/20 | 13:09
Half-year ReportWed 04/03/20 | 07:00
Data for peanut allergy vaccine published in JACIWed 29/01/20 | 12:00
Trading Update & Notice of Results - ReplacementThu 16/01/20 | 12:25
Half Year Trading Update & Notice of ResultsThu 16/01/20 | 07:00
Holdings in CompanyMon 02/12/19 | 09:57
Holdings in CompanyFri 29/11/19 | 10:34
Update to Grass MATA MPL Ph III clinical programmeTue 26/11/19 | 07:00
Result of Annual General MeetingMon 25/11/19 | 12:13
Annual Report and AccountsTue 22/10/19 | 09:23
Preliminary ResultsWed 25/09/19 | 07:00
Trading updateThu 11/07/19 | 07:00
Successful Litigation SettlementThu 27/06/19 | 07:00
Trading StatementThu 27/06/19 | 07:00
Board ChangeWed 19/06/19 | 07:00
Holdings in CompanyTue 11/06/19 | 07:00
Positive top line phase I results for Acarovac MPLMon 20/05/19 | 07:00
Holdings in CompanyTue 14/05/19 | 07:00
Holding(s) in CompanyMon 13/05/19 | 18:14
Second Price Monitoring ExtnMon 13/05/19 | 16:41
Price Monitoring ExtensionMon 13/05/19 | 16:35
Regulatory and Trading UpdateThu 25/04/19 | 07:00
Second Price Monitoring ExtnMon 18/03/19 | 16:41
Price Monitoring ExtensionMon 18/03/19 | 16:36
Second Price Monitoring ExtnMon 18/03/19 | 11:05
Price Monitoring ExtensionMon 18/03/19 | 11:00
Second Price Monitoring ExtnMon 18/03/19 | 09:05
Price Monitoring ExtensionMon 18/03/19 | 09:00
Top Line Phase III results from B301 trialMon 18/03/19 | 07:00
Interim ResultsWed 06/03/19 | 07:00
Trading Update & Notice of ResultsWed 16/01/19 | 07:00
Holdings in CompanyThu 29/11/18 | 17:59
Result of AGMTue 27/11/18 | 13:12
AGM Trading UpdateTue 27/11/18 | 07:00
Directorate ChangeThu 08/11/18 | 07:00
Holdings in CompanyWed 07/11/18 | 18:06
Grant of Awards under Long Term Incentive PlanFri 02/11/18 | 07:00
Holdings in CompanyWed 24/10/18 | 13:25
Director/PDMR ShareholdingWed 24/10/18 | 07:00
Annual Report and AccountsTue 23/10/18 | 17:29
Holdings in CompanyTue 23/10/18 | 15:28
Preliminary ResultsWed 26/09/18 | 07:00
Notice of ResultsWed 08/08/18 | 07:00
Holding(s) in CompanyFri 27/07/18 | 17:26
Holding(s) in CompanyThu 26/07/18 | 12:02
Results of Placing and SubscriptionThu 19/07/18 | 10:19
Proposed placing & subscription to raise £10.6mThu 19/07/18 | 07:00
BLOCK LISTING SIX MONTHLY RETURNMon 16/07/18 | 08:53
Trading UpdateThu 12/07/18 | 07:00
Positive top-line results from Grass Ph II studyMon 21/05/18 | 07:00
Grant of Awards under Long Term Incentive PlanFri 16/03/18 | 15:38
Director/PDMR ShareholdingFri 16/03/18 | 12:53
Interim ResultsWed 07/03/18 | 07:00
Polyvac® Peanut CMO appointedWed 28/02/18 | 07:00
Completion of recruitment in PQ Grass Ph II trialMon 12/02/18 | 07:00
Trading UpdateWed 31/01/18 | 07:00
Holdings in CompanyWed 10/01/18 | 15:19
PQ Birch Phase III trial completes recruitmentTue 09/01/18 | 07:00
Holding(s) in CompanyThu 07/12/17 | 17:08
Result of AGMWed 22/11/17 | 11:36
Block Listing ApplicationTue 21/11/17 | 07:00
Director/PDMR ShareholdingTue 07/11/17 | 12:59
Publication of Annual Report and notice of AGMThu 19/10/17 | 16:14
Commencement of dosing in PQ Grass Phase II TrialThu 19/10/17 | 07:00
Holding(s) in CompanyThu 12/10/17 | 17:39
Director/PDMR ShareholdingThu 12/10/17 | 14:55
Preliminary ResultsThu 28/09/17 | 07:00
Approval for PQ Grass Phase II trialMon 18/09/17 | 07:00
Expansion of Clinical Development and R&D teamsMon 11/09/17 | 07:00
Notice of ResultsTue 15/08/17 | 07:00
Trading UpdateTue 18/07/17 | 07:00
Satellite Symposium at EAACI 2017Mon 19/06/17 | 07:00